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The glucose transporter was identified and characterized bycytochalasin B binding in subcellular membrane fractions 
of chromaffin tissue. The binding was saturable with a Kd of about 0.3/zM for each subceilular f action. The Bm~ capacity 
was 12-16 pmol/mg protein for enriched plasma membrane fractions, 6.3 pmol/mg protein for mierosomal membrane 
preparations and 5.4 pmol/mg protein for chromaitin granule membranes. Irreversible photoaffinity labelling of the glu- 
cose-protectable inding sites with [aH]cytochaiasin B followed by solubilization and polyacrylamide g l electrophoresis 
from enriched plasma membrane preparations demonstrated the presence of three molecular species: 97+ 10, 51.5 + 6 
and 30 + 4 kDa. The chromaffin granule membranes showed only a molecular species of 80__+ 10 kDa. 
Glucose transporter; Chromaffin cell; Photoatfinity labeling; Cytochalasin B 
1. INTRODUCTION 
Chromaff in  cells f rom adrenal medulla are a 
useful tool in understanding secretory processes in 
neural cells [1,2]. They have also proved to be an 
interesting model in metabolite transport studies 
and their modulat ion in homogeneous neural 
tissue [3-5]. 
Under normal conditions, glucose serves as vir- 
tually the sole substrate for neural energy 
metabol ism [6], this also being true for chromaff in 
cells [7,8], which moreover show a similar 
glycolytic isoenzyme pattern to that found in brain 
and neural tissues [8,9]. 
The glucose transport and transporters in neural 
tissues have been characterized [10,11], even for 
chromaff in  cells [12], and the stimulatory effects 
o f  secretagogues and insulin established [13]. 
Nevertheless, little attention has been paid to 
glucose transporter distribution in this tissue, 
which presents the peculiar characteristic of  large 
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quantities o f  storage granules being clearly dif- 
ferent f rom fibroblasts and adipose tissue, where 
the transporters have been mainly characterized 
[14,15]. 
The present article deals with the glucose trans- 
porter subcellular distribution in chromaff in tissue 
and the molecular characterization, by using [3H]- 
cytochalasin B as a radioligand. 
2. MATERIALS  AND METHODS 
[4(n)-3H]Cytochaiasin B (15.5 Ci/mmol) was obtained from 
Amersham. Unlabelled cytochalasin B and cytochalasin E were 
purchased from Aldrich. All other eagents were obtained from 
Merck, Sigma and Boehringer. 
Subcellular f actions from adrenal medulla were obtained ac- 
cording to Zinder et al. [16] in the presence of 5/~M phenyl- 
methylsulfonyl f uoride (PMSF) to avoid protease action. 
Enzymatic assays for different fractions were: 5'-nucleotidase 
(EC 3.1.3.5) according to Aronson and Touster [17] and acetyl- 
cholinesterase (EC 3.1.1.7) by the method of Low and Finean 
[ 18] as markers of plasma membranes; monoamine oxidase (EC 
1.4.3.4) as described by Goridis and Neff [19], used as a 
mitochondrial marker enzyme and dopamine-B-hydroxylase 
(EC 1.14.17.1) according to Miras-Portugal et al. [20] as the en- 
zymatic marker of chromaffin granules. Proteins were deter- 
mined by the procedure of Bradford [21]. 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/88/$3.50 © 1988 Federation of European Biochemical Societies 35 
Volume 229, number 1 FEBS LETTERS February 1988 
Glucose transporter quantification was pecformed by cyto- 
chalasin B binding assays, essentially as in [13,14]. 
Photolabelling with [3H]cytochalasin B was carried out ac- 
coramg to Shanahan [22]. Characterization f photolabelled 
polypeptides was effected by polyacrylamide g l electrophoresis 
according to Laemmli [23]. Values are expressed as means ± 
SD. Linear regression equations were calculated by the least- 
squares method, using a linear regression program. 
3. RESULTS 
3.1. Enzyme marker distribution in chromuffin 
cells 
The data in table 1 list the activities of  some con- 
ventional enzyme markers of  plasma membranes, 
mitochondr ia and chromaff in granules. From 
these results the most characteristic constituent o f  
chromaff in granules, dopamine-B-hydroxylase, 
was preferentially associated with the chromaff in 
granule fraction in the gradient, but a significant 
activity was also present in the G3 fraction. The 
mitochondrial  enzyme monoamine oxidase was 
principally associated with the G3 fraction but  
significant amounts were also present in the 
chromaff in  granule fraction. Acetylcholinesterase 
and 5'-nucleotidase showed the large distribution 
of  plasma membranes through the gradient due to 
the heterogeneous size o f  vesicles formed f rom 
plasma membranes during the homogenization 
step procedure, as reported by others [16]. The GI 
and G2 fractions showed the highest specific ac- 
tivities o f  acetylcholinesterase and 5 '-nucleotidase 
with, at the same time, the lowest enzymatic ac- 
tivities o f  markers of  mitochondria nd chromaf-  
fin granules. Also the microsomal fraction (P 
100000 x g) was studied and its enzymatic levels 
ill 
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Fig.l. Scatchard analysis of equilibrium [3H]cytochalasin B 
binding to enriched fraction of plasma membrane preparations, 
0.4 mg protein (Gt fraction) was incubated with 
[3H]cytochalasin B (range 50-500/~M) and 5/~M cytochalasin E,
in the presence (H)  or absence (O----O) of 500 mM D- 
glucose. This plot is typically representative of four similar ex- 
periments performed in triplicate. 
are given in table 1. Recently, acetylcholinesterase 
and other enzyme markers for plasma membrane 
have also been found as constituents of  chromaff in 
granule membranes [24]. Nevertheless, these en- 
zymatic markers will provide us with a real ap- 
proach to study the subcellular distribution of  
glucose transporters. 
Table I 
Distribution of marker enzymes in sucrose density fractions of adrenal medulla 
Fraction Protein (e/e) 5 '-Nuclcotidase Acetylcholinesterase Monoamine oxidase Dopamine-ff-hydroxylase 
S 800xg 100.0 2.3 (100) 17.1 (100) 1.7 (100) 31.5 (100) 
P 10000 x g 34.0 3.2 (45) 27.4 (42.5) 4.2 (80) 78.8 (81) 
Gt 3.0 7.4 (10) 82.2 (15) 0.3 (0.5) 
G2 6.5 6.4 (18) 60.5 (23) 0.8 (3) 2.4 (0.5) 
G3 6.6 7.0 (20) 41.5 (16) 12.5 (48) 57.3 (12) 
C.G. 14.8 0.7 (5) 8.8 (7.6) 1.6 (13) 155.0 (73) 
P 100000 x g 6.7 4.0 (22) 28.0 (11) 0.9 (3.5) 4.6 (1) 
S 100000 x g 53.0 0.2 (4.6) 0.9 (3) 2.4 (4) 
Enzymes activities are expressed as specific activity in nmol/min per mg protein (e/e of total activity between parentheses). Gt, G2 and 
G3 fractions correspond to interfaces of 0.32-0.95, 0.95-1.34 and 1.34-1.6 M sucrose, respectively; C.G., chromaffin granules, ob- 
tained according to section 2 
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Table 2 
Distribution of glucose transporters in sucrose density fractions of adrenal medulla, measured by 
[3H]cytochalasin B binding 
Fraction Kd (aM) Bmax (pmol/mg protein) % total bound 
P 10000 x g 0.27 + 0.03 5.09 + 0.94 82.37 
GI 0.27 + 0.09 16.27 + 5.15 13.76 
G2 0.31 ± 0.02 12.16 + 1.18 28.61 
G3 0.42 ± 0.08 7.09 ± 1.37 14.25 
C.G. 0.20 ± 0.03 5.41 ± 0.38 22.44 
P 100000 x g 0.26 ± 0.13 6.34 ± 0.56 17.64 
Bmax corresponds to the difference between the maximal bound capacity in the presence or 
absence of glucose (specific binding). Results are means + SD of three experiments in duplicate 
3.2. Cytochalasin B binding distribution studies 
Fig. 1 illustrates Scatchard plots of the [3H]cyto- 
chalasin B binding data in plasma membranes (G~ 
fraction) of chromaffin tissue. In order to quantify 
the number of glucose transporters, maximal cyto- 
chalasin binding was measured in the presence or 
absence of D-glucose, the difference being due to 
specific binding, that corresponds toabout 20°70 of 
total ligand binding (specific binding = 
16.28 + 5.15 pmol/mg protein). The Ka value was 
0.27 + 0.09/zM. 
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Fig.2. Distribution of radioactivity and proteins on SDS- 
polyacrylamide gels from [3H]cytochalasin B-labelled plasma 
membrane proteins. Fraction (3] membranes (1 mg/ml) were 
labelled in the presence of 0.5/~M [3H]cytochalasin B (15.5 
Ci/mmol) and 100/~M cytochalasin E, in the presence (¢ ¢) 
or absence (O---O) of 500 mM D-glucose. The samples were 
photolyzed with ultraviolet light (280 nm, 5 rain). In both cases, 
aliquots containing 50 pg protein were subjected to SDS gel 
eiectrophoresis u ing 10% polyacrylamide gels. 
Similar experiments were carried out with each 
fraction from the gradient and the results obtained 
are summarized in table 2. The maximal binding 
capacity correlates well with the presence of en- 
zyme markers of plasma membranes, fractions G~ 
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Fig.3. Distribution of radioactivity and proteins on SDS- 
polyacrylamide g ls from [3H]cytochalasin B-labelled chromaf- 
fin granule membrane proteins. Membranes (1 mg/ml) were 
labelled in the presence of 0.5/zM [3H]cytochalasin B (15.5 
Ci/mmol) and 100pM cytochalasin E, in the presence (¢ ¢) 
or absence (O-----O) of 500 mM glucose. The samples were 
photolyzed with ultraviolet light (280 nm, 5 rain). In both cases, 
aliquots containing 100/~g protein were subjected to SDS elec- 
trophoresis using 12% polyacrylamide gels. 
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ty of chromaffin granule membranes (specific 
binding = 5.41 + 0.38 pmol/mg protein), that 
could not be explained by plasma membrane con- 
tamination. 
3.3. ffH]Cytochalasin photoaffinity labelling of 
glucose-protectable inding sites 
Photoaffinity labelling studies were effected 
with enriched plasma membrane (G1) and 
chromaffin granule membrane preparations. Fig.2 
shows the photoincorporation f [3H]cytochalasin 
B into plasma membrane polypeptides after ultra- 
violet light stimulation, which was analyzed by 
SDS-polyacrylamide g l electrophoresis. The pat- 
tern obtained for specific binding showed the 
presence of three molecular species with molecular 
masses of 97 + 10, 51.5 + 6 and 30 + 4 kDa. When 
chromaffin granule membranes were studied 
(fig.3) only one molecular polypeptide with 
specific photolabelling for cytochalasin B was 
found, its molecular mass in SDS gel electro- 
phoresis being 80 _+ 10 kDa. 
4. DISCUSSION 
Specific glucose-displaceable cytochalasin B 
binding is an important tool for investigating 
quantitatively the glucose transporters in cellular 
and particulate tissue preparations. In all of the 
brain membranes the affinity constants are close to 
0.3/zM [10]. Our results indicate the presence of a 
single class of saturable binding sites with a similar 
dissociation constant for each subcellular f action. 
The maximal binding capacity of the P 10000 x g 
fraction present in chromaffin tissue correlates 
well with similar fractions from cerebral cortex 
and cerebellum from pig and rat brain [10,11]. 
When more enriched fractions from neuro- 
blastoma nd astrocytes were compared, the values 
reported were also very similar to that found in 
chromaffin tissue membrane preparations 
(12-16 pmol/mg protein) [25]. 
The maximal bound capacity throughout he 
gradient agrees well with the plasma membrane 
distribution, except for the chromaffin granule 
fraction, where there is a significant bound capaci- 
ty not explainable by the plasma membrane con- 
tamination. 
The insulin effect upon glucose transport by in- 
creasing the glucose transporters at the plasma 
membrane l vel through their translocation from a 
microsomal pool is well known [15,26]. The 
presence of these transporters in microsomal mem- 
brane preparations (P 100000 x g) correlates well 
with the insulin effect observed in this peripheral 
neural tissue, where insulin receptors have been 
described [131. Furthermore, nicotine and other 
secretagogues increase the number of glucose 
transporters at the plasma membrane level of 
chromaffin cells [13]. However, the subcellular 
origin of these transporters is not well understood. 
In this way, the presence of high levels of glucose- 
displaceable cytochalasin B binding in the 
chromaffin granule fractions could shed some light 
and explain the increased number of glucose trans- 
porters when the regulated exocytotic event takes 
place. But the question arising is where and when 
the glucose transporters reach the chromaffin 
granule membranes. Two main possibilities exist 
(i) during the organelle biogenesis or (ii) after the 
exocytotic event when the plasma and chromaffin 
granule membranes undergo exocytosis for recy- 
cling. In both cases incomplete separation between 
the regulated and constitutive exocytotic pathways 
could be supposed [27,28]. 
The photolabelling studies effected with cyto- 
chalasin B showed a very different pattern when 
plasma membrane and chromaffin granule mem- 
branes were compared. In plasma membranes, 
three molecular species were photolabelled by 
cytochalasin B, suggesting the existence of three 
binding sites specifically protectable by glucose 
which could correspond to monomeric and dimeric 
forms of the transporter, as described in 
adipocytes and erythrocytes [29]. However, there 
is no clear proof that all are actually forms of the 
transporter. Nevertheless, the 30 kDa peptide 
could be the deglycosylated protein resulting from 
the action of glycosidases present as plasma mem- 
brane contamination, as confirmed elsewhere [30]. 
At the granule membrane l vel, only one molecular 
mass form was observed, which could correspond 
to the dimer. The differences in molecular masses 
of the labelled glucose transporters could be due to 
the degree of transporter glycosylation [31]. The 
possible existence of a different glucose trans- 
porter or other molecular species able to be photo- 
labelled by [3H]cytochalasin B in the presence of 
cytochalasin E and glucose could not be excluded. 
Additional studies are required to confirm the 
38 
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identity of these transporters and their functionali- 
ty or physiological functions when they are inside 
the cells. 
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